During the double-blind period of ATAMS , annualised relapse rates were higher in the atacicept groups than in the placebo group ( atacicept @ mg , @ , @ % CI @-@ ; @ mg , @ , @-@ ; @ mg , @ , @-@ ; placebo , @ , @-@ ) .